Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR3 | P46089 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.33 |
| ▸ | PARP14 | Q460N5 | 1/20 | 0.32 |
| ▸ | TNKS | O95271 | 1/20 | 0.30 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21454079 | 0.93 | GPR3 (0.40) | GPR3MAPTALDH1A1HPGDRAB9A | |
| SCHEMBL21454133 | 0.89 | GPR3 (0.37) | GPR3MAPTALDH1A1HPGDRAB9A | |
| SCHEMBL21453523 | 0.89 | GPR3 (0.37) | GPR3MAPTALDH1A1HPGDRAB9A | |
| SCHEMBL21453477 | 0.87 | GPR3 (0.41) | GPR3MAPTALDH1A1HPGDRAB9A | |
| SCHEMBL21454062 | 0.86 | GPR3 (0.37) | GPR3MAPTALDH1A1HPGDRAB9A | |
| SCHEMBL19890696 | 0.85 | GPR3 (0.42) | GPR3MAPTALDH1A1HPGDRAB9A | |
| SCHEMBL21453644 | 0.84 | GPR3 (0.37) | GPR3MAPTALDH1A1HPGDRAB9A | |
| SCHEMBL19563760 | 0.82 | GPR3 (0.48) | GPR3MAPTALDH1A1HPGDRAB9A | |
| SCHEMBL21454134 | 0.80 | GPR3 (0.37) | GPR3MAPTALDH1A1HPGDRAB9A | |
| SCHEMBL21454057 | 0.80 | GPR3 (0.38) | GPR3MAPTALDH1A1HPGDRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11038121-B2 | 9 membered ring carbazole compounds | Beijing Summer Sprout Technology Co., Ltd. (CN) | 2021-06-15 | — | — | US | disclosed |
| US-20190312214-A1 | 9 MEMBERED RING CARBAZOLE COMPOUNDS | BEIJING SUMMER SPROUT TECHNOLOGY CO., LTD (CN) | 2019-10-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11038121-B2 | 9 membered ring carbazole compounds | SLC25A21, OCIAD2, OXA1L | GPR3 478/4885MAPT 2041/4885ALDH1A1 802/4885 |
| US-20190312214-A1 | 9 MEMBERED RING CARBAZOLE COMPOUNDS | SLC25A21, OCIAD2, OXA1L | GPR3 478/4885MAPT 2041/4885ALDH1A1 802/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.